Posted on October 3, 2014 by Sitemaster
An article just published on line in Clinical Cancer Research supposedly reports the discovery of a single nucleotide polymorphism or SNP that may be useful in predicting which patients with Gleason 7 disease are most likely to have a more aggressive form of cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: aggressiveness, biomarker, Gleason, grade, KLK3, nucleotide, polymorphism, single, SNP | 1 Comment »
Posted on November 29, 2009 by Sitemaster
Frankly … not that much … but a new “brief review” in BJU International provides a good summary of the little that we really do know about the variations between specific areas of human DNA (“gene polymorphism”) and the relationship of such genetic variation to risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: gene, polymorphism, variation | Leave a comment »
Posted on March 21, 2009 by Sitemaster
This weekend’s news reports include items on:
- Androgen pathway genes and prostate cancer risk
- Pre-treatment PSA doubling time and prediction of Gleason score
- The diagnosis of prostate cancer in men with a diagnosis of HG-PIN
- Neoadjuvant hormone therapy in men undergoing brachytherapy
- Acupuncture as a means to manage hot flashes … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: acupuncture, androgen pathway genes, brachytherapy, Diagnosis, HG-PIN, hot flashes, neoadjuvant hormone therapy, polymorphism, pre-treatment PSA doubling time | 2 Comments »